Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $72.52 --0%
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia and MediaTek expand partnership, Nvidia invests $3.5b
- Femcare acquires UK harm reduction firm Orion for £3.6M
- Bernstein SocGen Group Reiterates Outperform Rating on SpaceX (SPCX)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
